| Product Name | MF | CAS | Details |
|---|
| 2-Methoxy-3-methylbenzaldehyde | C9H10O2 | 67639-61-6 | Details |
| tert-Butyl N-[1-(morpholin-2-yl)ethyl]carbamate | C11H22N2O3 | 1394041-38-3 | Details |
| tert-Butyl 6-hydroxy-6-(trifluoromethyl)-2-azaspiro[3.3]heptane-2-carboxylate | C12H18F3NO3 | 1251923-04-2 | Details |
| AIFM3 antibody | Details |
| 3-[(tert-Butoxy)carbonyl]pyrazine-2-carboxylic acid | C10H12N2O4 | 1909324-88-4 | Details |
| 1-[(4-Fluorophenyl)methyl]cyclopentane-1-carboxylic acid | C13H15FO2 | 1225506-32-0 | Details |
| Paeoniflorigenone | C17H18O6 | 80454-42-8 | Details |
| 3'-O-Acetyl-5'-O-tert-butyldiphenylsilyl-2'-deoxy-2'-fluorothymidine | C28H33FN2O6Si | Details |
| A1-Phytoprostane-I | C18H28O4 | 1035557-09-5 | Details |
| 4-(4-Bromo-3-methyl-1H-pyrazol-1-yl)butanoic acid | C8H11BrN2O2 | 1006495-34-6 | Details |
| Foravirumab | 944548-38-3 | Details |
| VZV Antibody Negative Human Plasma | Details |
| rac-(3R,3aR,6aS)-3-Methoxy-hexahydro-1H-furo[3,4-b]pyrrole | 2248367-05-5 | Details |
| PRDX4 antibody | Details |
| N-Ethyl-4-oxopiperidine-1-carboxamide | C8H14N2O2 | 675112-78-4 | Details |
| 4-((4-(2,4-Dichlorophenyl)-3-ethylthiazol-2(3H)-ylidene)amino)benzenesulfonamide | C17H15Cl2N3O2S2 | 2561476-24-0 | Details |
| Methyl 5-(1-chloroethyl)-3-methylfuran-2-carboxylate | C9H11ClO3 | 1421601-77-5 | Details |
| [2-(Dimethylamino)-1-methyl-1H-imidazol-5-yl]methanol | C7H13N3O | 1341502-23-5 | Details |
| Bifenox | C14H9Cl2NO5 | 42576-02-3 | Details |
| YGSY2P-IN-1 | C16H11F3N2O4 | 2415003-97-1 | Details |
| (5-Methyloxolan-2-yl)methanesulfonyl chloride | C6H11ClO3S | 1548474-19-6 | Details |
| 1-[(1,4-Oxazepan-4-yl)methyl]cyclopentane-1-carboxylic acid hydrochloride | 2230799-78-5 | Details |
| 1,5-Diphenyl-4-carboxy-1,2,3-triazole | C15H11N3O2 | 4900-34-9 | Details |
| 2-Chloro-N-(3-Trifluoromethyl-Phenyl)-Propionamide | C10H9ClF3NO | 36040-85-4 | Details |
| 7-Amino-1-phenylheptan-1-one hydrochloride | 2248386-31-2 | Details |
| (2-Methylcyclohexyl)methanol | C8H16O | 2105-40-0 | Details |
| Ethylene glycol monosalicylate | C9H10O4 | 87-28-5 | Details |
| 4-bromo-2-methanesulfonylaniline | C7H8BrNO2S | 1396554-49-6 | Details |
| TMEM132B Blocking Peptide | Details |
| HEPACAM2 protein (His tag) | Details |
| tert-Butyl oxazol-5-ylcarbamate | C8H12N2O3 | 1346809-07-1 | Details |
| 2-[3-(Trifluoromethyl)phenyl]propan-2-amine hydrochloride | C10H12F3N | 153390-61-5 | Details |
| (Z)-2-(Hydroxyimino)-2,3-dihydro-1H-inden-1-one | C9H7NO2 | 80070-34-4 | Details |
| PSG6 antibody | Details |
| 3-Chloro-4-morpholino-1,2,5-thiadiazole | C6H8ClN3OS | 30165-96-9 | Details |
| 5'-Deoxy-5-fluoro-5'-iodo-2',3'-O-isopropylidenecytidine | C12H15FIN3O4 | 61787-05-1 | Details |
| 4-{[(tert-butoxy)carbonyl]amino}oxane-4-carboxylic acid | C11H19NO5 | 172843-97-9 | Details |
| Epi-aflatoxin Q1 | C17H12O7 | 56648-94-3 | Details |
| 7,8-Dimethoxy-1,2,3,4-tetrahydroisoquinoline | C11H15NO2 | 52759-08-7 | Details |
| 6-Chloro-7-methylchromone-2-carboxylic acid | C11H7ClO4 | 262590-94-3 | Details |
| 2-(5-Bromo-2-fluorophenyl)ethan-1-amine | C8H9BrFN | 615534-62-8 | Details |
| 1-{Bicyclo[1.1.1]pentan-1-yl}piperazine | C9H16N2 | 2167346-89-4 | Details |
| 2-Hydroxydibenzofuran | C12H8O2 | 86-77-1 | Details |
| EFNB1 protein (His tag) | Details |
| 4-chlorobenzo[4,5]thieno[2,3-d]pyrimidine | C10H5ClN2S | 40142-92-5 | Details |
| 2,6-Dichloro-4-fluorobenzenesulfonyl chloride | C6H2Cl3FO2S | 88972-04-7 | Details |
| 3,5-Di-tert-butyl-4-hydroxybenzylaldehyde | C15H22O2 | 1620-98-0 | Details |
| 1-Acetylisatin | C10H7NO3 | 574-17-4 | Details |
| Deiodo amiodarone hydrochloride | C25H31ClINO3 | 1397201-93-2 | Details |
| 2-Chloro-N-[3-(thiomorpholine-4-carbonyl)phenyl]acetamide | C13H15ClN2O2S | 1221724-55-5 | Details |
| Human RBP4 ELISA Kit | Details |
| 1-Methyleffusol | C18H18O2 | 144106-78-5 | Details |
| Ethyl 2-[(4-{[(tert-butoxy)carbonyl]amino}phenyl)methyl]-1,3-thiazole-4-carboxylate | C18H22N2O4S | 1461708-07-5 | Details |
| GT2-Oligosaccharide | Details |
| 3-Oxo-3-phenyl-N-pyridin-3-yl-propionamide | C14H12N2O2 | 72742-89-3 | Details |
| 2,6-Dibromo-3,5-dimethoxyphenol | 3410-81-9 | Details |
| (3R)-3-Bromopyrrolidine hydrochloride | C4H9BrClN | 1354010-12-0 | Details |
| 5-(3,3-Difluorocyclobutyl)-1H-pyrazol-3-amine | C7H9F2N3 | 1425931-95-8 | Details |
| 2-Chloro-4-(1H-pyrazol-1-yl)pyridine | C8H6ClN3 | 1209459-70-0 | Details |
| 1-Methyl 2-Boc-2-azabicyclo[2.1.1]hexane-1-carboxylate | C12H19NO4 | 116129-01-2 | Details |
| 2-Acetamido-1,2-dideoxynojirimycin hydrochloride | C8H17ClN2O4 | 1356848-49-1 | Details |
| (D-Leu6,Pro-NHEt 9)-LHRH (4-9) | C37H62N10O8 | 202333-85-5 | Details |
| 2-p-Tolyloxazole | C10H9NO | 62882-04-6 | Details |
| (5-Chloro-2,1,3-benzothiadiazol-4-yl)thiourea | C7H5ClN4S2 | 51323-05-8 | Details |
| Saprorthoquinone | C20H24O2 | 102607-41-0 | Details |
| (S)-Carazolol hydrochloride | C18H22N2O2 | 78859-33-3 | Details |
| Hexyl isocyanate | C7H13NO | 2525-62-4 | Details |
| N-Boc-5'-chloro-5'-deoxy-2,3-O-isopropylideneadenosine | Details |
| 2,6-Di-tert-butylpyrimidin-4-amine | C12H21N3 | 69050-90-4 | Details |
| 2-[(2-Bromophenyl)amino]cyclohexan-1-ol | C12H16BrNO | 1183650-24-9 | Details |
| 4-Ethyl-N-(4-methoxyphenyl)-4,5-dihydro-1,3-thiazol-2-amine | C12H16N2OS | 380436-92-0 | Details |
| Tumor necrosis factor antibody (HRP) | Details |
| Securinine mononitrate | C13H16N2O5 | 7104-26-9 | Details |
| N3-PEG-PEG3-Glu[Cyclo(Arg-Gly-Asp-D-Tyr-Lys)]2 | Details |
| Tumor necrosis factor antibody (biotin) | Details |
| 2-Oxo-1-phenyl-1,2-dihydropyridine-3-carboxylic acid | C12H9NO3 | 868171-81-7 | Details |
| 3-{Methyl[(oxiran-2-yl)methyl]amino}propanenitrile | C7H12N2O | 3647-35-6 | Details |
| RNF126 Blocking Peptide | Details |
| 1-(3-Methyl-2-nitrophenyl)methanamine hydrochloride | 2866335-40-0 | Details |
| GOLM1 antibody (FITC) | Details |
| 1-Ethenylcyclobutan-1-amine hydrochloride | C6H12ClN | 1416374-23-6 | Details |
| 2-(Benzylsulfanyl)-1,3-benzoxazol-5-amine | C14H12N2OS | 1291356-99-4 | Details |
| H-VFSVSLSNPSTGK-OH | Details |
| 2-Cyclopentyl-1-(2,3-dihydro-1,4-benzodioxin-2-yl)ethan-1-amine | C15H21NO2 | 1483159-28-9 | Details |
| 1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl 2-{[(tert-butoxy)carbonyl]amino}acetate | C15H16N2O6 | 91837-43-3 | Details |
| Human Thyroxine ELISA kit | Details |
| 4'-Hydroxy-4-nitrostilbene | C14H11NO3 | 19221-08-0 | Details |
| 5-Deoxy-5-[di-(2-hydroxyethyl)-amino]-1,2-O-isopropylidene-a-D-xylofuranose | C12H23NO6 | 957505-60-1 | Details |
| 3-(Dimethyl-1H-1,2,4-triazol-1-yl)piperidine | C9H16N4 | 1249679-72-8 | Details |
| 3-Amino-N-(4-iodophenyl)benzene-1-sulfonamide | C12H11IN2O2S | 721414-88-6 | Details |
| HCMV IE1 81-89 (HLA-A*02:01) | Details |
| SARS-CoV-2 NSP13 (466-480) | Details |
| GSK3beta antibody | Details |
| XRRA1 Blocking Peptide | Details |
| OR10Z1 antibody | Details |
| 1-[(3-Fluorophenyl)methyl]cyclohexane-1-carboxylic acid | C14H17FO2 | 1490700-62-3 | Details |
| 2-{[2-(Methylsulfanyl)phenoxy]methyl}oxirane | C10H12O2S | 13379-85-6 | Details |
| 2-Cyclohexyl-N-[2-(2,3-dihydro-1H-indol-3-yl)ethyl]acetamide | C18H26N2O | 1042654-05-6 | Details |
| 4-[(5-Bromo-2-furoyl)amino]benzoic acid | C12H8BrNO4 | 723755-27-9 | Details |
| N-[(4-Fluorophenyl)methyl]-4-phenyl-1,3-thiazol-2-amine | C16H13FN2S | 724414-30-6 | Details |
| Product Total： Product Page： | ||||
| 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 | ||||